Work

OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’

Year: 2015

Type: article

Source: Journal of Antimicrobial Chemotherapy

DOI: 10.1093/jac/dkv166

Authors: Akihiro Morinaka, Yuko Tsutsumi, Mototsugu Yamada, Kenji Suzuki, Takashi Watanabe, Takao Abe, Takeshi Furuuchi, Seiichi Inamura, Yoshiaki Sakamaki, Nakako Mitsuhashi, Takashi Ida, David M. Livermore

Institutions: Meiji Seika Pharma Co., Ltd. (Japan), University of East Anglia

Language: English

Topic: Antibiotic Resistance in Bacteria

Subfield: Molecular Medicine

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Meiji Seika Pharma

OpenAlex ID: W2106565661

FWCI: 6.661

Cites: 32

Cited by: 185

Related to: 10